The struggling biotech firm, NovaGen Therapeutics, faced significant fiscal difficulties stemming from disappointing clinical trials and growing debt. Their internal team lacked the expertise to manage the https://anniebwap437848.blogdigy.com/biotech-cfo-services-a-case-study-in-financial-restructuring-66133042